Mankind Pharma acquires Rivotril brand for India
Acquires exclusive rights to manufacture, market and distribute Rivotril in India Adds a clonazepam Textbook brand with strong clinical legacy and specialist recall Strengthens Mankind Pharma’s strategic focus on chronic and CNS therapies Creates a platform for future expansion through potential line extensions India healthysoch New Delhi, March 19, 2026:




